Evaluation of the GenoType® MTBDRsl assay in Korean patients with MDR or XDR tuberculosis

References

• World Health Organization. Global tuberculosis report 2014. Geneva: World Health Organization, 2014.
   Google Scholar
• Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000-2004. MMWR. 2006;55:301.
   PubMedGoogle Scholar
• Korea Centers for Disease Control and Prevention. Annual Report on the Notified Tuberculosis in Korea 2012. Korea Centers for Disease Control and Prevention, 2013.
   Google Scholar
• Choi J, Jung Y-G, Kim J, et al. Rapid antibiotic susceptibility testing by tracking single cell growth in a microfluidic agarose channel system. Lab Chip. 2013;13:280–287.
   PubMed Web of Science ®Google Scholar
• Choi J, Yoo J, Lee M, et al. A rapid antimicrobial susceptibility test based on single-cell morphological analysis. Sci Transl Med. 2014;6:267ra174.
   PubMed Web of Science ®Google Scholar
• Hillemann D, Rüsch-Gerdes S, Richter E. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol. 2009;47:1767–1772.
   PubMed Web of Science ®Google Scholar
• Brossier F, Veziris N, Aubry A, et al. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J Clin Microbiol. 2010;48:1683–1689.
   PubMed Web of Science ®Google Scholar
• Kiet VS, Lan NTN, An DD, et al. Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis. J Clin Microbiol. 2010; 48:2934–2939.
   PubMed Web of Science ®Google Scholar
• Huang W-L, Chi T-L, Wu M-H, Jou R. Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2011;49:2502–2508.
   PubMed Web of Science ®Google Scholar
• Kontsevaya I, Mironova S, Nikolayevskyy V, et al. Evaluation of two molecular assays for rapid detection of Mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and-multidrug-resistance settings. J Clin Microbiol. 2011;49:2832–2837.
   PubMed Web of Science ®Google Scholar
• Ignatyeva O, Kontsevaya I, Kovalyov A, et al. Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study. J Clin Microbiol. 2012;50:1593–1597.
   PubMed Web of Science ®Google Scholar
• Lacoma A, Garcia-Sierra N, Prat C, et al. GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol. 2012;50:30–36.
   PubMed Web of Science ®Google Scholar
• Said HM, Kock MM, Ismail NA, et al. Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs. Int J Tuberc Lung D. 2012;16:104–109.
   PubMed Web of Science ®Google Scholar
• Tessema B, Beer J, Emmrich F, et al. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia. BMC Infect Dis. 2012;12:37.
   PubMed Web of Science ®Google Scholar
• Feng Y, Liu S, Wang Q, et al. Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis. PloS One. 2013;8:e55292.
   PubMed Web of Science ®Google Scholar
• Ajbani K, Nikam C, Kazi M, et al. Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments. PloS One. 2012;7:e49433.
   PubMed Web of Science ®Google Scholar
• Via LE, Cho S-N, Hwang S, et al. Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean patients with drug-resistant tuberculosis. J Clin Microbiol. 2010;48:402–411.
   PubMed Web of Science ®Google Scholar
• Park C, Sung N, Hwang S, et al. Evaluation of reverse hybridization assay for detecting fluoroquinolone and kanamycin resistance in multidrug-resistance mycobacterium tuberculosis clinical isolates. Tuberc Respir Dis. 2012;72:44–49.
   Google Scholar
• Kim C-K, Lee BS, Choi MJ, et al. Molecular detection of fluoroquinolone resistance in multidrug-resistant mycobacterium tuberculosis isolates. Ann Clin Microbiol. 2014;17:80–85.
   Google Scholar
• Shim TS, Jo K-W. Medical treatment of pulmonary multidrug-resistant tuberculosis. Infect Chemother. 2013;45:367–374.
   PubMedGoogle Scholar
• Chakravorty S, Kothari H, Aladegbami B, et al. Rapid, high-throughput detection of rifampin resistance and heteroresistance in Mycobacterium tuberculosis by use of sloppy molecular beacon melting temperature coding. J Clin Microbiol. 2012;50:2194–2202.
   PubMed Web of Science ®Google Scholar
• Kim S, Hong Y. Drug resistance of Mycobacterium tuberculosis in Korea. Tuber Lung Dis. 1992;73:219–224.
   PubMedGoogle Scholar
• Jnawali HN, Hwang SC, Park YK, et al. Characterization of mutations in multi-and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea. Diagn Micr Infec Dis. 2013;76:187–196.
   PubMed Web of Science ®Google Scholar
• Hillemann D, Weizenegger M, Kubica T, et al. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol. 2005;43:3699–3703.
   PubMed Web of Science ®Google Scholar
• Huang W-L, Chen H-Y, Kuo Y-M, Jou R. Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2009;47:2520–2524.
   PubMed Web of Science ®Google Scholar
• Lacoma A, Garcia-Sierra N, Prat C, et al. GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol. 2008;46:3660–3667.
   PubMed Web of Science ®Google Scholar
• Kim S, Bai G, Hong Y. Drug-resistant tuberculosis in Korea, 1994. Int J Tuberc Lung Dis. 1997;1:302–308.
   PubMed Web of Science ®Google Scholar
• Canetti G, Fox W, Khomenko Aa, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ. 1969;41:21.
   PubMed Web of Science ®Google Scholar
• Piersimoni C, Olivieri A, Benacchio L, Scarparo C. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems. J Clin Microbiol. 2006;44:20–28.
   PubMed Web of Science ®Google Scholar
• Dye C. Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nat Rev Microbiol. 2009;7:81–87.
   PubMed Web of Science ®Google Scholar
• Fidler DP, Gostin LO, Markel H. Through the quarantine looking glass: drug‐resistant tuberculosis and public health governance, law, and ethics. J Law Med Ethics. 2007;35:616–628.
   PubMed Web of Science ®Google Scholar
• Törün T, Güngör G, Özmen I, et al. Side effects associated with the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2005;9:1373–1377.
   PubMed Web of Science ®Google Scholar
• Bang D, Andersen ÅB, Thomsen VØ. Rapid genotypic detection of rifampin-and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. J Clin Microbiol. 2006;44:2605–2608.
   PubMed Web of Science ®Google Scholar
• Hillemann D, Rüsch-Gerdes S, Richter E. Application of the Genotype® MTBDR assay directly on sputum specimens. Int J Tuberc Lung Dis. 2006;10:1057–1059.
   PubMed Web of Science ®Google Scholar
• Traore H, van Deun A, Shamputa IC, et al. Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay. J Clin Microbiol. 2006;44:4384–4388.
   PubMed Web of Science ®Google Scholar
• Lee H, Kim J, Kim H, et al. Colour-barcoded magnetic microparticles for multiplexed bioassays. Nat Mater. 2010;9:745–749.
   PubMed Web of Science ®Google Scholar
• Han S, Bae HJ, Kim J, et al. Lithographically encoded polymer microtaggant using high‐capacity and error‐correctable QR code for anti‐counterfeiting of drugs. Adv Mater. 2012;24:5924–5929.
   PubMed Web of Science ®Google Scholar
• Chung SE, Kim J, Oh DY, et al. One-step pipetting and assembly of encoded chemical-laden microparticles for high-throughput multiplexed bioassays. Nat Commun. 2014;5:3468.
   PubMedGoogle Scholar
• Kim LN, Kim M, Jung K, et al. Shape-encoded silica microparticles for multiplexed bioassays. Chem Commun. 2015;60:12130–12133.
   Web of Science ®Google Scholar